MedTrace Logo

Transfusion Trigger After Operations in High Cardiac Risk Patients

NCT03229941 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1424

Last updated 2025-11-21

Study results available
· View outcomes & findings →

Summary

The goal of the proposed study is to determine whether a liberal transfusion strategy (transfusion trigger at Hb \< 10 gm/dl) in Veterans at high cardiac risk who undergo major open vascular and general surgery operations is associated with decreased risk of adverse postoperative outcomes compared to a restrictive transfusion strategy (transfusion trigger at Hb \< 7 gm/dl).

Conditions

Interventions

PROCEDURE

Blood Transfusion

Blood Transfusion

Sponsors & Collaborators

  • VA Office of Research and Development

    lead FED

Principal Investigators

  • Panagiotis Kougias, MD MSc · VA New York Harbor Health Care System, Brooklyn Campus

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-02-05
Primary Completion
2023-06-02
Completion
2024-03-02

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03229941 on ClinicalTrials.gov